Lifesciences and digital health strategist, investment professional, entrepreneur and executive who has a passion for blending emerging technologies, business and science. Drawing insights from 50+ cross-sector deals, co-creation of 5 NewCos, $70+M in Series A fundraising, and an Artificial Intelligence (AI) based not-for-profit coalition, effectuates partnerships and unconventional models of investment to parties with shared common goals.
With a focus on Nanotechnology, Nanoelectronics, Data as a Centralised Platform and Artificial Intelligence (AI), Mawambo helps collaborators access, develop and deploy innovative and targeted solutions at the confluence of consumer and healthcare sectors to support health and well-being. With a global health, end-user, and patient-centered mindset, we support innovations that drive access to effective, lower-cost, scalable and sustainable healthcare solutions.
Nanotechnology, nanoelectronics, and AI to support data generation, integration and analytics to augment socio-behavioral and clinical decision-making including drugs, devices and digital health
Academia, Private Equity, Venture Capital, Payors, Health Systems, CROs, Retail Pharmacy, Government, Foundations, BioPharma and, Technology and Nanoelectronic Companies
Cardiology, Dermatology, Gastroenterology, Geriatrics, Immunology & Inflammation, Infectious Diseases, Metabolic Disorders, Neurology and Mental Health, Oncology, Orphan and Neglected Diseases, Pathology, Population Health, Radiation Oncology, Radiology
Ambulatory Care, Home Health, In-patient care, Intensive and Critical Care (ICU), Nursing Homes, Occupational Health, Palliative Care, Surgery, Urgent Care
Identify problems and driving forces with focus on related health-settings and end-user preferences accounting for provider, patient, and consumer needs
Evaluate and/or establish killer niche applications and development roadmaps with emphasis on technology capabilities, risk profile, proof points, high-value use cases, regulatory environment, and capital needs
Integrate Subject-Matter-Experts (SME) and insights into practical solution development including targeted workshops and roundtables
Define and anticipate market entry, growth, and competitive strategies including asset sourcing, partnering, and acquisitions for differentiated positioning
Serve multiple functions across technical, business and operations
Develop & implement sustainable and scalable business models to deliver value to shareholders and stakeholders i.e., technology innovators, drug and device manufacturers, care providers, payors, patients, investors
Through board and advisory roles influence and guide vision & strategic planning for organizations, health technologies, and products
Health Systems & Payers
Growth Phase
Start-Ups
Incubators &
Venture Studios
Technology & Electronics
Academia & Foundations
Socio-behavioral and workplace champion for comprehensive approach to optimize health & well-being
Learn moreCross-sector versatile strategist, asset and capabilities hunter, and broker
Learn moreChampion for data integration, analysis and responsible use for Precision & Digital Health
Learn more
“Annastasiah brings positive and high energy to the projects and organizations she engages with. The diversity of the subject matter to which this drive has been targeted is equally striking.
A natural adventure leader.”
Philip Goelet, PhDCEO & President Evobiotics, Acidophil; Partner, Red Abbey Venture Partners
“I was highly skeptical about the whole project but Annastasiah, through force of energy and vision, convinced me – and importantly the Hopkins faculty and leadership – that this project could truly transform medical diagnostics. In all her work at Hopkins, Annastasiah worked on behalf of the investigators and the vision to produce tangible results, even when most felt they could not be achieved. These characteristics built a trust and admiration on the part of her faculty that endures to this day”.
Drew Pardoll, MD., PhDDirector of the Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine
RARE Drug Development Symposium June 2020 View Key Takeaways
BIO-Digital, Can AI prevent Pandemics? June 2020 View Digital Sessions
AI Application in BioPharma Summit, Boston Oct 2020
2nd Annual Pharma AI Summit, Zurich Postponed to 2021
Bio-IT World Expo, Boston Oct 2020
Mawambo LLC
100 International Dr. Fl. 23
Baltimore MD 21202
Copyright © 2020 Mawambo - All Rights Reserved.
Seoul, Korea: TV Chosun 6th Global Leaders Forum